PIPERACEAE Piper nigrum  L.

 Synonym

  • PIPERACEAE Piper aromaticum  Lam.
 Thai / English name

  • พริกไทย*

[1-3] of 3 article(s) found

 หน้า  1  2  

[1] CYP3A4 AND CYP2D6 INHIBITORY ACTIVITIES OF INDONESIAN MEDICINAL PLANTS.
USIA T,IWATA H,HIRATSUKA A,ET AL.
PHYTOMEDICINE 2006 Vol.13(),67-73  $14378 [Full]

Part Used : ผล
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : methanol
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 1.65 mg/ml of water extract powder
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : Erythromycin*/Erythrocin
Dose/Conc.(drug) : -
Result : Positive
Remark : Among the MeOH-soluble fractions, Piper nigrum leaf showed the highest inhibitory activity against CYP3A4 (91.7%) and Punica granatum against CYP2D6 (98.1%). The water extract MeOH-soluble fraction showed inhibitory activity more than 70% were fractionated with EtOAc. The most potent inhibitory activity against CYP3A4 (IC50 avlue of 25 mg/ml) was found for the extract of Pi. nigrum leaf, while that of Catharanthus roseus showed the most potent inhibitory effect against CYP2D6 (IC50 value of 11 mg/ml).
Note : Ketoconazole and quinidine (1 micromolar) were used as the positive control for CYP3A4 and CYP2D6, respectively.

Part Used : ผล
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : ethylacetate
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 1.65 mg/ml of water extract powder
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : Erythromycin*/Erythrocin
Dose/Conc.(drug) : -
Result : Positive
Remark : Among the MeOH-soluble fractions, Piper nigrum leaf showed the highest inhibitory activity against CYP3A4 (91.7%) and Punica granatum against CYP2D6 (98.1%). The water extract MeOH-soluble fraction showed inhibitory activity more than 70% were fractionated with EtOAc. The most potent inhibitory activity against CYP3A4 (IC50 avlue of 25 mg/ml) was found for the extract of Pi. nigrum leaf, while that of Catharanthus roseus showed the most potent inhibitory effect against CYP2D6 (IC50 value of 11 mg/ml).
Note : Ketoconazole and quinidine (1 micromolar) were used as the positive control for CYP3A4 and CYP2D6, respectively.

Part Used : ใบ
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : ethylacetate
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 1.65 mg/ml of water extract powder
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : Erythromycin*/Erythrocin
Dose/Conc.(drug) : -
Result : Positive
Remark : Among the MeOH-soluble fractions, Piper nigrum leaf showed the highest inhibitory activity against CYP3A4 (91.7%) and Punica granatum against CYP2D6 (98.1%). The water extract MeOH-soluble fraction showed inhibitory activity more than 70% were fractionated with EtOAc. The most potent inhibitory activity against CYP3A4 (IC50 avlue of 25 mg/ml) was found for the extract of Pi. nigrum leaf, while that of Catharanthus roseus showed the most potent inhibitory effect against CYP2D6 (IC50 value of 11 mg/ml).
Note : Ketoconazole and quinidine (1 micromolar) were used as the positive control for CYP3A4 and CYP2D6, respectively.

[2] EFFECTS OF MACE AND NUTMEG ON HUMAN CYTOCHROME P450 3A4 AND 2C9 ACTIVITY.
KIMURA Y,ITO H,HATANO T
BIOL PHARM BULL 2010 Vol.33(12),1977-82  $33078 [Full]

Part Used : ไม่ระบุ
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : Black pepper
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 100 microgram/ml
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : IC50=4.1 microgram/ml

Part Used : ไม่ระบุ
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : White pepper
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 100 microgram/ml
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : IC50=1.0 microgram/ml

[3] CYTOCHROME P450 INHIBITORY POTENTIAL AND RP-HPLC STANDARDIZATION OF TRIKATU—A RASAYANA FROM INDIAN AYURVEDA.
RANJIT K. HARWANSH,KAKALI MUKHERJEE,SANTANU BHADRA,ET AL.
J ETHNOPHARMACOL 2014 Vol.153(),674-81  $51721 [Full]

Part Used : ผล
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : Ethanol
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 800-6.5 micrograms/mL
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : Result: IC50 value of extracts on metabolism mediated by CYP3A4 and CYP2D6 were 174.20+/-1.90 and 220.11+/-1.90 micrograms/mL, respectively.
Note : Type of experiment: rat liver microsomes. The amount of 6-gingerol present in extract of Zingiber officinal, Trikatumarketed formulation and Trikatu laboratory formulation was estimated to be about 6.21+/-1.03%, 5.3+/-1.21% and 4.95+/-2.34% (w/w), respectively. Piperine was found to be 7.31+/-2.36% (Piper longum), 8.41+/-2.54% (Piper nigrum), 7.89+/-2.12% (Trikatu marketed formulation) and 6.70+/-2.13% (w/w) (Trikatu laboratory formulation).

Part Used : ผล
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : DMSO (Dimethyl Sulfoxide)
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 800-6.5 micrograms/mL
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : Result: IC50 value of extracts on metabolism mediated by CYP3A4 and CYP2D6 were 178.34+/-2.14 and 234.90+/-2.90 micrograms/mL, respectively.
Note : Type of experiment: rat liver microsomes. The amount of 6-gingerol present in extract of Zingiber officinal, Trikatumarketed formulation and Trikatu laboratory formulation was estimated to be about 6.21+/-1.03%, 5.3+/-1.21% and 4.95+/-2.34% (w/w), respectively. Piperine was found to be 7.31+/-2.36% (Piper longum), 8.41+/-2.54% (Piper nigrum), 7.89+/-2.12% (Trikatu marketed formulation) and 6.70+/-2.13% (w/w) (Trikatu laboratory formulation).

Part Used : ผล
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : piperine ethanol
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 800-6.5 micrograms/mL
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : Result: IC50 value of extracts on metabolism mediated by CYP3A4 and CYP2D6 were 222.95+/-2.15 and 266.32+/-2.41 micrograms/mL, respectively.
Note : Type of experiment: rat liver microsomes. The amount of 6-gingerol present in extract of Zingiber officinal, Trikatumarketed formulation and Trikatu laboratory formulation was estimated to be about 6.21+/-1.03%, 5.3+/-1.21% and 4.95+/-2.34% (w/w), respectively. Piperine was found to be 7.31+/-2.36% (Piper longum), 8.41+/-2.54% (Piper nigrum), 7.89+/-2.12% (Trikatu marketed formulation) and 6.70+/-2.13% (w/w) (Trikatu laboratory formulation).

Part Used : ผล
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : piperine DMSO (Dimethyl Sulfoxide)
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 800-6.5 micrograms/mL
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : Result: IC50 value of extracts on metabolism mediated by CYP3A4 and CYP2D6 were 221.73+/-4.88 and 269.46+/-1.67 micrograms/mL, respectively.
Note : Type of experiment: rat liver microsomes. The amount of 6-gingerol present in extract of Zingiber officinal, Trikatumarketed formulation and Trikatu laboratory formulation was estimated to be about 6.21+/-1.03%, 5.3+/-1.21% and 4.95+/-2.34% (w/w), respectively. Piperine was found to be 7.31+/-2.36% (Piper longum), 8.41+/-2.54% (Piper nigrum), 7.89+/-2.12% (Trikatu marketed formulation) and 6.70+/-2.13% (w/w) (Trikatu laboratory formulation).

Part Used : เหง้า
Activity : CYP3A4 INHIBITION
Solvent/Active Compound : Trikatu laboratory formulation / Ethanol
Type of experiment : in vitro
Type of animal : -
Type of study : -
N(Total) : -
N(Treatment) : -
Sex : -
Age : -
Route : -
Dose/Conc.(herb) : 800-6.5 micrograms/mL
Duration : -
Type of interaction : Pharmacokinetics
Interaction with drug : -
Dose/Conc.(drug) : -
Result : Positive
Remark : Result: IC50 value of extracts on metabolism mediated by CYP3A4 and CYP2D6 were 203.14+/-1.89 and 233.76+/-2.13 micrograms/mL, respectively.
Note : Type of experiment: rat liver microsomes. The amount of 6-gingerol present in extract of Zingiber officinal, Trikatumarketed formulation and Trikatu laboratory formulation was estimated to be about 6.21+/-1.03%, 5.3+/-1.21% and 4.95+/-2.34% (w/w), respectively. Piperine was found to be 7.31+/-2.36% (Piper longum), 8.41+/-2.54% (Piper nigrum), 7.89+/-2.12% (Trikatu marketed formulation) and 6.70+/-2.13% (w/w) (Trikatu laboratory formulation).


 หน้า  1  2